Seeing Is Believing

Currently out of the existing stock ratings of Ben Haynor, 117 are a BUY (86.67%), 18 are a HOLD (13.33%).
Analyst Ben Haynor, currently employed at LAKE STREET, carries an average stock price target met ratio of 50.17% that have a potential upside of 44.6% achieved within 252 days. Previously, Ben Haynor worked at AEGIS, BAML, ALLIANCE GLOBAL PARTNERS, FELTL.
Ben Haynor’s has documented 249 price targets and ratings displayed on 33 stocks. The coverage is on Healthcare, Technology, Basic Materials, Industrials sectors.
Most recent stock forecast was given on PIII, P3 Health Partners at 15-May-2026.
Analyst best performing recommendations are on EKSO (EKSO BIONICS HOLDINGS).
The best stock recommendation documented was for DRIO (DARIOHEALTH CORP) at 8/17/2021. The price target of $255 was fulfilled within 10 days with a profit of $43.8 (20.74%) receiving and performance score of 20.74.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 13-Aug-2025
11 months ago
(13-Aug-2025)
0/1 (0%)
$-18.2 (-78.45%)
Buy Since 22-Mar-2021
$500
1 years 4 months 3 days ago
(11-Mar-2025)
0/2 (0%)
$203.8 (68.80%)
Buy Since 14-May-2022
2 years 11 months 3 days ago
(11-Aug-2023)
3/4 (75%)
$51.8 (29.07%)
58
Buy Since 06-Jun-2019
$540
3 years 2 months 2 days ago
(12-May-2023)
4/5 (80%)
$146.4 (37.20%)
176
Buy Since 17-Aug-2020
$500
3 years 10 months 26 days ago
(18-Aug-2022)
0/2 (0%)
$335.2 (203.40%)
Which stock is Ben Haynor is most bullish on?
Which stock is Ben Haynor is most reserved on?
What Year was the first public recommendation made by Ben Haynor?